Synthesis and evaluation of antimicrobial, antitubercular and anticancer activities of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamides
- PMID: 29804151
- PMCID: PMC5971037
- DOI: 10.1186/s13065-018-0432-3
Synthesis and evaluation of antimicrobial, antitubercular and anticancer activities of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamides
Abstract
Background: The study describes the synthesis, characterization, in vitro antimicrobial and anticancer evaluation of a series of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamide derivatives. The synthesized derivatives were also assessed for in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv. The compounds found active in in vitro study were assessed for their in vivo antitubercular activity in mice models and for their inhibitory action on vital mycobacterial enzymes viz, isocitrate lyase, pantothenate synthetase and chorismate mutase.
Results: Compounds 8, 9 and 11 emerged out as excellent antimicrobial agents in antimicrobial assays when compared to standard antibacterial and antifungal drugs. The results of anticancer activity displayed that majority of the derivatives were less cytotoxic than standard drugs (tamoxifen and 5-fluorouracil) towards MCF7 and HCT116 cell lines. However, compound 2 (IC50 = 0.0047 µM/ml) and compound 10 (IC50 = 0.0058 µM/ml) showed highest cytotoxicity against MCF7 and HCT116 cell lines, respectively. The results of in vivo antitubercular activity revealed that a dose of 1.34 mg/kg was found to be safe for the synthesized compounds. The toxic dose of the compounds was 5.67 mg/kg while lethal dose varied from 1.81 to 3.17 mg/kg body weight of the mice. Compound 18 inhibited all the three mycobacterial enzymes to the highest level in comparison to the other synthesized derivatives but showed lesser inhibition as compared to streptomycin sulphate.
Conclusions: A further research on most active synthesized compounds as lead molecules may result in discovery of novel anticancer and antitubercular agents.
Keywords: Cytotoxic; In vitro; Isocitrate lyase; MCF7, HCT116; Pantothenate synthetase; Resistance.
Figures
Similar articles
-
Synthesis, characterization, biological evaluation and molecular docking studies of 2-(1H-benzo[d]imidazol-2-ylthio)-N-(substituted 4-oxothiazolidin-3-yl) acetamides.Chem Cent J. 2017 Dec 22;11(1):137. doi: 10.1186/s13065-017-0361-6. Chem Cent J. 2017. PMID: 29274036 Free PMC article.
-
Design, synthesis, biological screening and molecular docking studies of novel multifunctional 1,4-di (aryl/heteroaryl) substituted piperazine derivatives as potential antitubercular and antimicrobial agents.Bioorg Chem. 2022 Feb;119:105568. doi: 10.1016/j.bioorg.2021.105568. Epub 2021 Dec 16. Bioorg Chem. 2022. PMID: 34968884
-
4-(2-(1H-Benzo[d]imidazol-2-ylthio)acetamido)-N-(substituted phenyl)benzamides: design, synthesis and biological evaluation.BMC Chem. 2019 Feb 2;13(1):12. doi: 10.1186/s13065-019-0533-7. eCollection 2019 Dec. BMC Chem. 2019. PMID: 31384761 Free PMC article.
-
Design, synthesis and therapeutic potential of 3-(2-(1H-benzo[d]imidazol-2-ylthio)acetamido)-N-(substituted phenyl)benzamide analogues.Chem Cent J. 2018 Dec 19;12(1):139. doi: 10.1186/s13065-018-0513-3. Chem Cent J. 2018. PMID: 30569392 Free PMC article.
-
2-Mercaptobenzimidazole Schiff Bases: Design, Synthesis, Antimicrobial Studies and Anticancer Activity on HCT-116 Cell Line.Mini Rev Med Chem. 2019;19(13):1080-1092. doi: 10.2174/1389557518666181009151008. Mini Rev Med Chem. 2019. PMID: 30306865
Cited by
-
Antimicrobial potential of 1H-benzo[d]imidazole scaffold: a review.BMC Chem. 2019 Feb 4;13(1):18. doi: 10.1186/s13065-019-0521-y. eCollection 2019 Dec. BMC Chem. 2019. PMID: 31384767 Free PMC article. Review.
-
Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules.Molecules. 2021 Dec 15;26(24):7611. doi: 10.3390/molecules26247611. Molecules. 2021. PMID: 34946704 Free PMC article. Review.
-
Synthesis and therapeutic potential of imidazole containing compounds.BMC Chem. 2021 Feb 18;15(1):12. doi: 10.1186/s13065-020-00730-1. BMC Chem. 2021. PMID: 33602331 Free PMC article. Review.
-
Benzimidazole scaffolds as promising antiproliferative agents: a review.BMC Chem. 2019 May 15;13(1):66. doi: 10.1186/s13065-019-0579-6. eCollection 2019 Dec. BMC Chem. 2019. PMID: 31384813 Free PMC article. Review.
-
Synthesis and effect of 4-acetylphenylamine-based imidazole derivatives on migration and growth of 3D cultures of breast, prostate and brain cancer cells.Sci Rep. 2024 Nov 14;14(1):28065. doi: 10.1038/s41598-024-76533-4. Sci Rep. 2024. PMID: 39543257 Free PMC article.
References
-
- Singh LR, Avula SR, Raj S, Srivastava A, Palnati GR, Tripathi CKM, Pasupuleti M, Sashidhara KV. Coumarin–benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation. J Antibiot. 2017 - PubMed
-
- WHO annual TB report 2017. http://apps.who.int/iris/bitstream/10665/254762/1/978929022584-eng.pdf. Accessed 24 July 2017
LinkOut - more resources
Full Text Sources
Other Literature Sources